Abstract
Background: Neo-adjuvant chemotherapy (NAC) has no survival advantage over adjuvant chemotherapy however it is increasingly being used as it provides in vivo tumour response and downsizing and down staging of the disease which can result in less invasive surgery in both breast and axilla. With the emerging trend of treatment de-escalation in breast cancer patients we aim to look at practice in our institution in breast cancer patient who undergo NAC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
